Cognition Therapeutics, Inc. (CGTX) Operating income 2020–2025
Cognition Therapeutics, Inc. (CGTX) annual operating income history from SEC filings — each fiscal year as reported.
-$47.8MFY2025 · since FY2020: -$17.4M → -$47.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$47.8M | +11.4% |
| FY2024 | -$54.0M | -6.4% |
| FY2023 | -$50.7M | -16.5% |
| FY2022 | -$43.6M | -52.3% |
| FY2021 | -$28.6M | -64.3% |
| FY2020 | -$17.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CGTX financial trends
CGTX RevenueCGTX Net incomeCGTX Net marginCGTX Gross profitCGTX Gross marginCGTX Operating marginCGTX Operating cash flowCGTX Free cash flowCGTX Capital expendituresCGTX Return on equityCGTX Stock buybacksCGTX Dividends paidCGTX Total assetsCGTX Total liabilitiesCGTX Shareholders’ equityCGTX overview →